This week, we sit down with John Faragon to discuss the clinical hold that's been lifted for lenacapavir - a drug used for HIV treatment. Now that the hold has been lifted, what's next? Tune in to learn all about what lenacapavir is, who it's for, and why HIV providers should be interested in this news.  --Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at [email protected] with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Ver todos los episodios